Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NUVASIVE INCNUVA · Entity 110002 | Chief Human Resources Officer | May 07, 2021 | May 11, 2021 |
| Orthofix Medical Inc.OFIX · Entity 1975 | CP&BOO | March 17, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NUVASIVE INC
Report date May 07, 2021 · Filed May 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,342 |
Reported balance
After 2021-05-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-07 · Sale · Disposed 2,208 · Balance 3,342 F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.
Orthofix Medical Inc.
Report date March 17, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 160,449 |
Reported balance
After 2026-03-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-17 · Sale · Disposed 4,269 · Balance 160,449 F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2: Includes 127,256 previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
F2: Includes 127,256 previously reported restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2026 Filed Mar 19, 2026 20:31 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,269 | $11.92 | $50,886.48 |
DisclosureSEC source: 0001193125-26-116071 · ownership.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,449 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 127,256 previously reported restricted stock units. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,141 | $12.55 | $14,320.46 |
DisclosureSEC source: 0001193125-26-096590 · ownership.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,718 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive. F3 · balance_after: Includes 138,173 previously reported restricted stock units. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 1,171 | $12.92 | $15,124.99 |
DisclosureSEC source: 0001193125-26-096590 · ownership.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,859 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · balance_after: Includes 138,173 previously reported restricted stock units. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:49 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 45,546 | $0.00 Strike: $13.03 | $0.00 |
DisclosureSEC source: 0001193125-26-094462 · ownership.xml · derivative · entry 2 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,546 Underlying: Common Stock · 45,546 shares Expires 2033-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 23:49 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 19,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-094462 · ownership.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,030 F1 · shares: Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. F2 · balance_after: Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:21 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,287 | $16.60 | $71,164.20 |
DisclosureSEC source: 0000950170-25-042692 · ownership.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · CP&BOO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,317 F1 · kind: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person. F2 · balance_after: Includes 123,894 previously reported restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 34,924 | $0.00 Strike: $16.98 | $0.00 |
DisclosureSEC source: 0000950170-25-033620 · ownership.xml · derivative · entry 2 Vitale Lucas · CIK 0001763869 · CP&BO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,924 Underlying: Common Stock · 34,924 shares Expires 2032-03-03 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,723 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-033620 · ownership.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · CP&BO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,604 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F2 · balance_after: Includes 120,087 previously reported restricted stock units. Read SEC document |
| May 07, 2021 Filed May 11, 2021 17:56 UTC | NUVASIVE INC NUVA · Entity 110002 | SaleCommon Stock | 2,208 | $68.23 | $150,651.84 |
DisclosureSEC source: 0001209191-21-031815 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,342 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 3,054 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030005 · doc4.xml · derivative · entry 4 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,054 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the RSU award, the award vested as to 3,054 shares on April 30, 2021. F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the RSU award, the award vested as to 3,054 shares on April 30, 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 321 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030005 · doc4.xml · derivative · entry 3 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 321 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 321 shares on April 30, 2021. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 321 shares on April 30, 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 1,167 | $71.45 | $83,382.15 |
DisclosureSEC source: 0001209191-21-030005 · doc4.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,550 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 191 shares acquired under the Issuer's employee stock purchase plan in April 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030005 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 191 shares acquired under the Issuer's employee stock purchase plan in April 2021. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | SaleCommon Stock | 4,306 | $68.19 | $293,626.14 |
DisclosureSEC source: 0001209191-21-026693 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantRSUs · Derivative | 5,893 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017156 · doc4.xml · derivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,893 Underlying: Common Stock · 5,893 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024. F2 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:47 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 321 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010335 · doc4.xml · derivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321 Underlying: Common Stock · 321 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 321 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 321 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 386 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044791 · doc4.xml · derivative · entry 3 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 386 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on August 1, 2018. In accordance with the terms of the RSU award, the award vested as to 386 shares on August 1, 2020. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on August 1, 2018. In accordance with the terms of the RSU award, the award vested as to 386 shares on August 1, 2020. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 133 | $57.14 | $7,599.62 |
DisclosureSEC source: 0001209191-20-044791 · doc4.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,457 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044791 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 354 shares acquired under the Issuer's employee stock purchase plan in April 2020. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantRSUs · Derivative | 4,953 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015526 · doc4.xml · derivative · entry 4 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,953 Underlying: Common Stock · 4,953 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023. F5 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 1,652 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015526 · doc4.xml · derivative · entry 3 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the RSU award, the award vested as to 1,652 shares on March 1, 2020. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the RSU award, the award vested as to 1,652 shares on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 633 | $65.81 | $41,657.73 |
DisclosureSEC source: 0001209191-20-015526 · doc4.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,850 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 436 shares acquired under the Issuer's employee stock purchase plan in April 2019. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 1,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015526 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 436 shares acquired under the Issuer's employee stock purchase plan in April 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantRSUs · Derivative | 5,130 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 5 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,130 Underlying: Common Stock · 5,130 shares Expires not disclosed F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022. F7 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2019. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2022. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 3,001 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 4 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the RSU award, the award vested as to 3,001 shares on March 1, 2019. F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the RSU award, the award vested as to 3,001 shares on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 991 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016854 · doc4.xml · derivative · entry 3 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 991 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 991 shares on March 1, 2019. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 991 shares on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 1,404 | $58.48 | $82,105.92 |
DisclosureSEC source: 0001209191-19-016854 · doc4.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,395 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:55 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 3,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016854 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 06, 2019 Filed Feb 7, 2019 18:02 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 991 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008201 · doc4.xml · derivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991 Underlying: Common Stock · 991 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 991 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 991 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:03 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 731 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006921 · doc4.xml · derivative · entry 3 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 731 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This RSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the RSU award, the award vested as to 732 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 731 shares on February 1, 2019. F4 · derivative.expiration_date: This RSU award was granted to the Reporting Person on February 17, 2015. In accordance with the terms of the RSU award, the award vested as to 732 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 731 shares on February 1, 2019. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:03 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 298 | $49.13 | $14,640.74 |
DisclosureSEC source: 0001209191-19-006921 · doc4.xml · nonDerivative · entry 2 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,807 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 18:03 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006921 · doc4.xml · nonDerivative · entry 1 Vitale Lucas · CIK 0001763869 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.